ライフサイエンスコーパス: smear

1 HWs were also taught to obtain a thick blood smear.

2 n than the standard sputum acid-fast bacilli smear.

3 ers on the presence of monoblasts in a blood smear.

4 ely and passively screened using thick blood smear.

5 with 69 prospectively collected clinical FNA smears.

6 d analysed with duplicate modified Kato-Katz smears.

7 eage, particularly lineage A, in both serial smears.

8 the low sensitivity and specificity of blood smears.

9 re tested for microfilaraemia by night blood smears.

10 l specimens including Papanicolaou and blood smears.

11 ed by positive results of acid-fast bacillus smears.

12 smear preparation, and interpretation of the smears.

13 nfection as measured by Kato-Katz (KK) fecal smears.

14 after treatment by quadruple Kato-Katz thick smears.

15 vary highly over repeated stool samples and smears.

16 is presented using liquid-based cytology Pap smears.

17 s, and the glass and the jamming regimes are smeared.

18 ry of a cervical procedure to treat abnormal smears]).

19 ients), hemagglutination on peripheral blood smear (36%), fatigue (64%), headaches (50%), fever (45%)

20 onding red blood cell pellets, including 185 smears (50.4%) that were positive by microscopy.

21 t predictors of RR-TB were a positive sputum smear (adjusted odds ratio [aOR] 2.42, 95% confidence in

22 se in the highest grade of acid-fast bacilli smear (AFS).

23 By contrast, the Fe distribution is smeared along an arc corresponding to the proposed path

24 verage increases from 81.3% accuracy without smear analysis to 93.9% with smear characterization and

25 ward simplifying and improving CBC and blood smear analysis, which is currently performed manually vi

26 Positive sputum smear and cavitary disease, correlates of disease burden

27 ructed a model using %SP on peripheral blood smear and CTP class.

28 A cohort of newly diagnosed, sputum smear and culture positive adult individuals with drug-s

29 4 patients clinically suspected for PTB with smear and culture reports, were analysed for sensitivity

30 We also extracted data on the smear and culture status of index cases, the age and bac

31 intensified active case-finding with sputum smear and culture testing monthly for 6 months and then

32 or scar size at 3 weeks and 3 months, 3-day smear and culture, and adverse events.

33 each evaluated with acid-fast bacilli (AFB) smear and mycobacterial culture using liquid and solid c

34 TB was diagnosed based on sputum smear and sensitive molecular and microbial tests.

35 about the true specificity of tests such as smear and Xpert-like tests in ACF, relating to the accur

36 finite elements (CSFEs) containing the fiber smeared and surrounding domains.

37 g the probed volume, which introduces signal smearing and precludes the scanning of complex structure

38 s were positive for acid-fast bacilli sputum smears and 43% had cavitary disease; at study entry, 35%

39 protocols for microscopic analysis of blood smears and bone marrow aspirates.

40 ess of this approach by imaging Papanicolaou smears and breast cancer tissue slides over a large fiel

41 We extracted DNA from archived blood smears and corresponding red blood cell pellets collecte

42 We analyzed a total of 367 blood smears and corresponding red blood cell pellets, includi

43 We evaluated induced sputum Gram stain smears and cultures from hospitalized children aged 1-59

44 Corneal smears and cultures were obtained from all study partici

45 Thick blood smears and RDTs were usually taken at hospital admission

46 The diagnostic yield, the cellularity of smears and the rate of acquiring sufficient histological

47 pondence between microscopic findings of Pap smears and the vaginal microbiota composition determined

48 (390,310 first abnormal and 1,951,319 normal smears) and in situ/invasive cervical cancer (75,128 cas

49 lar junctions are maintained is a measure of smear, and the resulting variance in unbiased single mea

50 and specificity were estimated for SMF, AFB smear, and Xpert MTB/RIF, using MGIT as the reference st

51 ing in the clinic for a routine Papanicolaou smear, and/or women seeking a routine gynecologic checku

52 rofiles, viral cycle thresholds (Cts), blood smears, and soluble C5b-9 values were analyzed with clin

53 ethods (flow cytometry, examination of blood smears, and T cell receptor gene rearrangements), and pe

54 The LAM-ELISA detected all smear- and MTB-culture-positive samples (n = 70) and 50%

55 n diagnosing pulmonary TB cases whose sputum smears are negative and making a correlation between the

56 uspected of having active pulmonary TB whose smears are negative can benefit from MD HRCT chest findi

57 Tissue smears are shown to give the same chemical information a

58 The presence of burr cells on blood smears, as well as Cts, differentiated between patients

59 ity prevalence of parasitemia on thick blood smear, assessed in a random sample of children from each

60 teins in the lactose excipient and found the smear band by silver staining, which was identified as b

61 nd sectioning, which we address by analyzing smeared biopsy tissue.

62 c predicted increased risk of positive blood smear but, interestingly, decreased risk of symptomatic

63 culations indicate that the Fermi surface is smeared by the disorder due to the presence of vacancies

64 try (DESI-MS) is used to characterize tissue smears by comparison with a library of DESI mass spectra

65 strate how binning measurements according to smear can significantly enhance the use of individual co

66 Therefore, blood smears can provide an adequate source of DNA for confirm

67 ccuracy without smear analysis to 93.9% with smear characterization and binning (SCRIB).

68 ica many falciparum-infected persons without smear-detectable gametocytes still infect mosquitoes.

69 The 8.4% of patients with smear-detectable gametocytes were >20 times more likely

70 Compared to microscopy, PCR-HRM analysis of smear DNA had a sensitivity of 93.0% (95% confidence int

71 In these measurements, "smearing" due to conformational changes and other entrop

72 were found in one-half of the margin biopsy smears, even in cases where postoperative MRI suggested

73 We collected blood smears every 2 weeks and during any illness for 24 weeks

74 Intraoperative DESI-MS analysis of tissue smears, ex vivo, can be inserted into the current surgic

75 blood samples after examination of 100 thick smear fields and only 2 of 20 demonstrated spirochetes w

76 en the examination was extended to 300 thick smear fields.

77 xamination findings, anal Papanicolaou (Pap) smear findings.

78 (2) a 3D continuum discretized by composite smeared finite elements (CSFEs) containing the fiber sme

79 esiosis, with no parasites detected on blood smear for at least the final 2 weeks of treatment.

80 ee image scanning cytometry of patient blood smears for automated malaria detection.

81 nclude that we were not able to obtain blood smears for microscopy for all suspected malaria cases, s

82 intraoperative DESI-MS evaluation of tissue smears for rapid diagnosis.

83 d the use of DNA extracts from stained blood smears for the detection of Plasmodium species using rea

84 as confirmed in Giemsa-reagent stained blood smears for the Type I sample.

85 ng Register (1969-2011) including 14,011,269 smears from 2,466,107 women, we conducted two nested cas

86 Spirochetes were not detected in the blood smears from 20 PCR positive patient blood samples after

87 length in genomic DNA extracted from buccal smears from 63 patients with BD, 74 first-degree relativ

88 ients, we made standard malariological thick smears from anticoagulated blood samples that were previ

89 logists performing a blind analysis of blood smears from healthy donors and thrombocytopenic and sick

90 g was performed at one wavenumber on the Pap smears from patients with specimens negative for intraep

91 say into both cancer cell lines and cervical smears from patients.

92 Patients aged 18 years or older with sputum smear grade 1+ or higher were eligible for enrolment, an

93 ctors were pulmonary tuberculosis and sputum smear grade, age, and the maximum number of hours any co

94 sult in only 1 of 3 samples, and 5 had a low smear grade.

95 than with Hain V1 and V2 in samples with low smear grades.

96 There was no difference in sputum smear grading and pulmonary cavitation.

97 group and 217 (5.3%) of 4093 patients in the smear group (pooled adjusted OR 0.88, 95% CI 0.68-1.14 [

98 vs 16.38 per 100 person-years in the sputum smear group) for HIV-positive patients (hazard ratio 0.7

99 roup) versus sputum smear microscopy (sputum smear group), across five low-income and middle-income c

100 nd determined the failure rate of Gram stain smears (GSS) due to insufficient cellular material.

101 terial morphotypes of a Gram-stained vaginal smear (i.e., Nugent scoring).

102 lso observed in aerosol samples collected at SMEAR II station (Hyytiala, Finland) in August 2015 sugg

103 ed in aerosol samples (PM1) collected at the SMEAR II station (Hyytiala, Finland) suggesting that DMA

104 Malaria was identified by blood smear in 10 of 18 patients (56%) on admission, and by ra

105 ariae speciation was correctly identified by smear in 2 of 18 (11%) patients.

106 Here, we show a method for characterizing smear in single-molecule conductance measurements and de

107 a methodology to unveil the signals that are smeared in the strong ambient noise and thus facilitate

108 soprene sources plus uncertainty and spatial smearing in the isoprene-formaldehyde relationship.

109 en (living in Kilifi, Kenyan Coast) by blood smears in 17 cross-sectional surveys to identify asympto

110 entation of erythrocytes in peripheral blood smear, increased plasma levels of lactate dehydrogenase

111 typical relapsing fever, microscopy of blood smears is not sensitive enough for confirming a diagnosi

112 opic examination of acid-fast-stained sputum smears is the current standard of care in the United Sta

113 gnosis of malaria using Giemsa-stained blood smears is the standard of care in resource-limited setti

114 dau level due to large electron-hole puddles smearing its energy landscape.

115 Smear layer and dentin erosion scores were analyzed with

116 GA showed the same ability to remove the smear layer and to cause dentin erosion as EDTA.

117 oot sections were obtained for evaluation of smear layer removal and dentin erosion on root segments

118 Specifically, changes in microhardness, smear layer removal, erosion, mineral content distributi

119 ed that GA has similar ability to remove the smear layer than EDTA.

120 four time periods with a fluxmeter: 1) with smear layer, 2) after 37% phosphoric acid etching, 3) af

121 To determine whether blood smears may detect B. miyamotoi in the blood of acute BMD

122 rofiling and examination of peripheral blood smears may distinguish between patients with MIS-C and t

123 hat infection, microscopy to analyze a blood smear, may have clinical utility.

124 esources, collecting multiple samples and/or smears means screening fewer individuals, thereby loweri

125 cleotide recognition when only low molecular smear measurements are used, which represents a signific

126 toms, obtained one induced sputum sample for smear microscopy (AFB) and mycobacterial culture, and pe

127 th Xpert MTB/RIF (Xpert group) versus sputum smear microscopy (sputum smear group), across five low-i

128 test for tuberculosis, compared with sputum smear microscopy (the standard of care).

129 microscopy laboratories compared with using smear microscopy against a reference standard of solid a

130 Sputum smear microscopy and BD MAX were performed on a single r

131 ammatic active case-finding entailing sputum smear microscopy and clinical assessment.

132 9 months of TB treatment, as well as sputum-smear microscopy and sputum-culture positivity at 2 and

133 Inclusion of smear microscopy and Xpert MTB/RIF (or MTB/RIF Ultra) as

134 hildren evaluated for pulmonary TB by sputum smear microscopy and Xpert MTB/RIF (Xpert) from February

135 76 clinical samples (56 positives using thin smear microscopy as the reference method and 20 negative

136 m falciparum infection was assessed by blood smear microscopy at all visits.

137 Sputum acid-fast bacilli (AFB) smear microscopy has suboptimal sensitivity but remains

138 Tests that can replace sputum smear microscopy have been identified as a top priority

139 Despite advances in diagnosis, smear microscopy insufficiently detects pulmonary diseas

140 For example, smear microscopy misses up to half of TB cases, yet is c

141 l to equal culture's sensitivity with sputum smear microscopy negative specimens and therefore cannot

142 ended by the World Health Organization for a smear microscopy replacement tuberculosis test.

143 he point-of-care by the Ziehl-Neelsen sputum smear microscopy test.

144 sis case detection of Gene drive, Xpert, and smear microscopy were 45.4% (95% confidence interval [CI

145 The sensitivities of culture, Xpert, and smear microscopy were estimated to be 60% (95% CrI: 46,

146 ard conventional methods (culture and direct smear microscopy).

147 mens were collected and tested by GeneXpert, smear microscopy, and culture.

148 d usually before a positive result on sputum smear microscopy, and showed a high burden of undetected

149 pectorate sputum, and were then evaluated by smear microscopy, BACTEC MGIT 960 Mycobacterial Detectio

150 ected from each inpatient and analyzed using smear microscopy, culture, drug susceptibility testing,

151 Per 1000 patients screened, and relative to smear microscopy, point-of-care Xpert cost an additional

152 orkers, and when compared with point-of-care smear microscopy, reduces time to diagnosis and pretreat

153 wing tests were used: mycobacterial culture, smear microscopy, Xpert MTB/RIF (Cepheid Inc.), tubercul

154 has greater sensitivity and specificity than smear microscopy-the most common sputum-based diagnostic

155 ly to offer good value for money relative to smear microscopy.

156 ctiveness of point-of-care Xpert relative to smear microscopy.

157 comparable to the gold standard of the blood smear microscopy.

158 more specific, and more cost-effective than smear microscopy.

159 eir speed and sensitivity compared to sputum smear microscopy.

160 ards for tuberculosis diagnosis, culture and smear microscopy.

161 Sputum smear-microscopy and BD MAX were performed on a single r

162 00]) for smear-positive samples (florescence smear-microscopy), and 81% (87/107, [73,88]) in smear-ne

163 of Gene drive and Xpert for the detection of smear-microscopy-negative tuberculosis were 0% (95% CI,

164 oplasma antigen test (n = 349 [18%]), fungal smear (n = 294 [15%]), or fungal culture (n = 223 [12%])

165 ts were recruited; 70 (81.4%) AFB microscopy smear negative and 16 (18.6%) AFB microscopy smear posit

166 Patients with smear negative disease and age </=10 years were less lik

167 of discriminating between those who were AFB smear negative in the diagnosis of PTB was good with cro

168 es to determine PTB status in AFB microscopy smear negative patients co-infected with HIV.

169 and Th2 cytokine response in AFB microscopy smear negative PTB-HIV co-infected patients.

170 The AFB microscopy smear negative samples were then cultured using Lowenste

171 ated in PTB culture-positive (AFB microscopy smear negative) as compared to PTB culture-negative (AFB

172 ared to PTB culture-negative (AFB microscopy smear negative) participants.

173 ll but 1 subject in the study remained blood-smear negative, while only 1 subject (primaquine/chloroq

174 esent in 34% of samples, and 25% were sputum smear negative.

175 imaquine/chloroquine subjects remained blood-smear negative.

176 imaquine/chloroquine subjects remained blood smear negative.

177 ; p=0.03), and were more likely to be sputum smear-negative (33 [62%] of 53 vs 62 [35%] of 179; p=0.0

178 ear-positive [AFB(+)] sputum, 59.3% with AFB smear-negative [AFB(-)] sputum), specificity of 99.2%, n

179 respectively, for the 137 participants with smear-negative and culture-positive sputum (difference o

180 In the new smear-negative and MDR TB cascades, a substantial propor

181 n India's TB cascade of care, especially for smear-negative and MDR TB patients.

182 ositive samples (n = 70) and 50% (n = 29) of smear-negative but culture-positive samples (n = 58) (ve

183 and 63% positivity among smear-positive and smear-negative confirmed ATB samples, respectively.

184 ere less likely to be linked than those with smear-negative disease.

185 81% sensitivity in sputum smear-positive and smear-negative groups, respectively.

186 1.43, 3.51) and among smear-positive versus smear-negative index cases (ratio of odds ratios = 5.45,

187 , the use of CF enhanced detection of sputum smear-negative individuals.

188 HIV-seronegative patients only when they are smear-negative or lack cavitary lung disease.

189 ents or of M. tuberculosis isolates from AFB smear-negative samples from patients in India suspected

190 ar-microscopy), and 81% (87/107, [73,88]) in smear-negative samples.

191 ce microscopy), and 81% (87/107 [73-88%]) in smear-negative samples.

192 % CI, 53.5% to 70.0%) for smear-positive and smear-negative TB, respectively, but varied widely by co

193 tra test with that of Xpert for detection of smear-negative tuberculosis and rifampicin resistance an

194 but one subject in the study remained blood smear-negative while only one subject (primaquine/chloro

195 sitive, culture-positive samples and 88% for smear-negative, culture-positive samples with a specific

196 orms of TB-including new smear-positive, new smear-negative, retreatment smear-positive, and multidru

197 During the same period, the annual number of smear-negative/culture-positive TB cases diagnosed overs

198 Comparison of the increase of smear-negative/culture-positive TB cases diagnosed overs

199 tions allowed footprint registration without smearing of skin texture patterns which consist of dense

200 Preliminary data suggests that lateral smearing of the focal spot can be simulated.

201 performed RDTs (SD-Bioline) and thick blood smears on all children suspected to have malaria.

202 s, supporting the theory that the biometer's smeared optical surface was responsible.

203 reassuring gynaecologists for the use of Pap smear or wet mount microscopy for rapid evaluation of va

204 DNA extracts from Giemsa-stained thick blood smears or corresponding blood pellets had high sensitivi

205 subjected to very fast spectral fluctuations smearing out any possible different information from the

206 The number of smear pairs (1.84 vs. 3.56; p < 0.001) and blood contami

207 unbiased single measurements depends on this smear parameter.

208 f stool samples per person and the number of smears per sample.

209 n chitosan-conditioned dentin, attributed to smear plug retention, also fostered long-term bond stabi

210 for retention of intrafibrillar minerals and smear plugs in dentin conditioned with 1 wt% chitosan.

211 vitary disease; at study entry, 35% remained smear positive after a median MDR-TB treatment duration

212 tive and bacteriologically confirmed (either smear positive or culture positive, or both) pulmonary t

213 Sputum smear positive patients (n = 25) provided sputum samples

214 World Health Organisation (WHO) estimates of smear positive TB prevalence from 1990 to 2014.

215 clinically significant disease and be sputum smear positive, thus warranting particular attention.

216 y and extrapulmonary TB, and 9/13 (69%) were smear positive.

217 smear negative and 16 (18.6%) AFB microscopy smear positive.

218 ients (2.5% of smear-positive patients) were smear positive/PCR negative; 8 of the 9 had a smear-posi

219 ity of 85.2% (96.7% in participants with AFB smear-positive [AFB(+)] sputum, 59.3% with AFB smear-neg

220 We identified 50 (0.2%) smear-positive and 101 (0.3%) bacteriologically confirme

221 sample design to estimate the prevalence of smear-positive and bacteriologically confirmed (either s

222 Retreatment smear-positive and MDR TB patients had poorer treatment

223 % vs. 56%) with 80% and 63% positivity among smear-positive and smear-negative confirmed ATB samples,

224 B/RIF had 100% and 81% sensitivity in sputum smear-positive and smear-negative groups, respectively.

225 d 62.0% (88/142; 95% CI, 53.5% to 70.0%) for smear-positive and smear-negative TB, respectively, but

226 35 (20%) home-discharged cases were smear-positive at discharge.

227 quality sequence data were obtained from one smear-positive culture-negative case.

228 cing data were obtained directly from all 24 smear-positive culture-positive sputa, of which 20 were

229 d in the network, while patients with sputum smear-positive disease were less likely to be linked tha

230 more than 2.5 was most accurate to identify smear-positive driveline infection.

231 lue (SUV) >2.5 was most accurate to identify smear-positive driveline infection.

232 cal trial included patients with culture- or smear-positive filamentous fungal corneal ulcer and a ba

233 inical trial that enrolled 240 patients with smear-positive filamentous fungal corneal ulcers who enr

234 Patients with smear-positive filamentous fungal ulcers and visual acui

235 >=5 years, male sex, non-US/Canadian birth, smear-positive index patient, and shared bedroom with an

236 Nine patients (2.5% of smear-positive patients) were smear positive/PCR negativ

237 For new smear-positive patients, pretreatment loss to follow-up

238 ned serial sputum samples from patients with smear-positive pulmonary TB who were consecutively enrol

239 , open-label trial in which individuals with smear-positive pulmonary TB with isoniazid resistance me

240 Xinjiang survey estimates, the prevalence of smear-positive pulmonary tuberculosis has decreased by 2

241 ohort study among adult patients treated for smear-positive pulmonary tuberculosis in 70 clinics acro

242 The new smear-positive pulmonary tuberculosis notification rate

243 The weighted prevalence of smear-positive pulmonary tuberculosis was 170 (95% CI 10

244 od by using the Illumina MiSeq sequencer (40 smear-positive respiratory samples obtained after routin

245 mear positive/PCR negative; 8 of the 9 had a smear-positive result in only 1 of 3 samples, and 5 had

246 sensitivity was 100% (175/175, [98,100]) for smear-positive samples (florescence smear-microscopy), a

247 sensitivity was 100% (175/175 [98-100%]) for smear-positive samples (fluorescence microscopy), and 81

248 A and gyrB genes of acid-fast bacillus (AFB) smear-positive sediments or of M. tuberculosis isolates

249 Of 323 participants with smear-positive specimens (183 men [56.7%]; 140 women [43

250 One hundred four DNA samples extracted from smear-positive sputum sediments, previously sequenced us

251 ients either had an MDR-TB risk factor and a smear-positive sputum specimen, but had PSQ performed on

252 ce were major points of attrition in the new smear-positive TB cascade.

253 prevalence-to-notification (P:N) ratios for smear-positive TB.

254 and 2.51 (95% CI 2.07-3.04; 40 surveys) for smear-positive TB.

255 Indonesian household contacts patients with smear-positive tuberculosis (TB) had an interferon-gamma

256 trospective cohort study of 85 patients with smear-positive tuberculosis and their 369 household cont

257 mplex directly in respiratory specimens from smear-positive tuberculosis cases from four different re

258 se in a hypothetical cohort of patients with smear-positive tuberculosis.

259 Of the 323 patients with smear-positive ulcers enrolled in MUTT-I, 299 (92.6%) we

260 A total of 151 patients with smear-positive ulcers were screened and 70 were enrolled

261 tal of 2133 patients in India and Nepal with smear-positive ulcers were screened; of the 787 who were

262 ratios = 2.24, 95% CI: 1.43, 3.51) and among smear-positive versus smear-negative index cases (ratio

263 ar-positive, new smear-negative, retreatment smear-positive, and multidrug-resistant (MDR) TB.

264 rent countries with a sensitivity of 89% for smear-positive, culture-positive samples and 88% for sme

265 ents with specific forms of TB-including new smear-positive, new smear-negative, retreatment smear-po

266 y and extrapulmonary TB, and 9/13 (69%) were smear-positive.

267 ctly observed therapy, and acid-fast-bacilli smear-positivity to obtain adjusted odds ratios (aORs) a

268 he process, including poor specimen quality, smear preparation, and interpretation of the smears.

269 Acid Fast Bacilli (AFB) microscopy smear remains the most widely used laboratory diagnostic

270 f diagnostic test accuracy studies of sputum smear-replacement tests.

271 These smears represent a potential source of DNA for PCR testi

272 pattern, previous treatment history, sputum smear result, and extent of disease on chest radiograph.

273 A peripheral blood smear revealed anemia, thrombocytopenia, and blast cells

274 Driveline smears revealed staphylococcus or pseudomonas strains as

275 Driveline smears revealed Staphylococcus or Pseudomonas strains as

276 ning for cervical cancer with a Papanicolaou smear, screening for gonorrhea and chlamydia).

277 ed countries where large numbers of archived smear slides could be used for retrospective (and prospe

278 les were obtained for direct fluorescent AFB smear, SMF, Xpert MTB/RIF, and MGIT culture media.

279 ung disease (P < 0.0001 for interaction) and smear status (P = 0.02 for interaction) of tuberculosis

280 d for 35 days for parasitemia by thick blood smear (TBS) and quantitative polymerase chain reaction (

281 d for 35 days for parasitemia by thick blood smear (TBS) and quantitative polymerase chain reaction.

282 hen parasitaemic, as detected by thick blood smear (TBS) microscopy.

283 e estrous cycle was measured using a vaginal smear test.

284 months and had a Giemsa-stained thick blood smear that was positive for P falciparum.

285 unfixed effusion fluid to produce air-dried smears that are stained with Wright-Giemsa or other Roma

286 t microscopy of Giemsa-stained patient blood smears to first enable detection and manual counting to

287 s, these two transitions become increasingly smeared together, so measuring a clear distinction betwe

288 sing automated analyzer and peripheral blood smear using Leishmann stain) and CTP class were assessed

289 While a positive 2-month smear was not significantly associated with an unsuccess

290 ectral imaging of single cells from the same smears was also performed to provide integral biochemica

291 In the absence of discharge, meatal smears were associated with a significant reduction in c

292 Clinical FNA smears were prospectively collected and analyzed using D

293 ia and Burkina Faso, RDT cassettes and blood smears were re-read by an experienced investigator at st

294 Archived Ziehl-Neelsen-stained sputum smears were used to conduct microbead-based spoligotypin

295 ith single MS scans of necrotic tumor tissue smears, which further accelerates the identification wor

296 l vertebrate carcasses, which they shave and smear with antimicrobial exudates.

297 scriminated between normal and cancerous Pap smears with 100% accuracy.

298 ing of biodegradation of hydrocarbons in the smear zone.

299 Smear zones that contained both LNAPL residual and trapp

300 t from light nonaqueous phase liquid (LNAPL) smear zones.